Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Plos One|January 18, 2013
Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activitySophie Daburon, Christel Devaud, Pierre Costet, et al.
International Journal of Cancer|January 11, 2019
FAK alternative splice mRNA variants expression pattern in colorectal cancerChristel Devaud, Anne-Françoise Tilkin-Mariamé, Alix Vignolle-Vidoni, et al.
Science Immunology|June 8, 2023
Distant antimetastatic effect of enterotropic colon cancer-derived α4β7Virginie Feliu, Carlos Gomez-Roca, Marie Michelas, et al.
Cancer Research|February 9, 2012
Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancerLiza B John, Linda J Howland, Jacqueline K Flynn, et al.
Cancers|August 12, 2022
Circulating Exhausted PD-1<sup>+</sup>CD39<sup>+</sup> Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis BlockadeCarlos Martinez-Gomez, Marie Michelas, Clara-Maria Scarlata, et al.
Oncoimmunology|November 1, 2021
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancersJuan-Pablo Cerapio, Marion Perrier, Camille-Charlotte Balança, et al.
Scientific Reports|March 27, 2024
The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancerGiulia Trimaglio, Tamara Sneperger, Benjamin B A Raymond, et al.
JCI Insight|December 17, 2020
PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cellsCamille-Charlotte Balança, Anna Salvioni, Clara-Maria Scarlata, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2013
Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapyChristel Devaud, Jennifer A Westwood, Liza B John, et al.
NPJ Precision Oncology|April 9, 2026
Terminal T-cell exhaustion predicts tumor control independent of immunotherapy in ovarian cancerAnna Salvioni, Marie Michelas, Mathilde Del, et al.
Pageof 4